grant

Randomised trial to determine the safety and efficacy of early vs deferred treatment of HIV [ 2012 - 2016 ]

Also known as: The Strategic Timing of AntiRetroviral Therapy trial: START

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1033140]

Researchers: Prof Sean Emery (Principal investigator) ,  A/Pr Edwina Wright A/Pr Gail Matthews Dr Sarah Pett Prof Jennifer Hoy

Brief description Treatments for HIV represent a miraculous achievement of medical research. Global use of antiretroviral drugs has prevented substantial morbidity and mortality. However, it is unclear if these drugs should be used in people who are HIV positive with early HIV disease but no clinical symptoms. The START trial will result in a precise estimate of the risk-benefit for earlier versus later use of these treatments. It will immediately affect treatment guidelines around the world and inform future research for many years to come.

Funding Amount $AUD 1,070,331.72

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]